Angela Hanson, MD
Geriatric Medicine · Seattle, WANPI 1790895969
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Novo Nordisk AS accounts for 95.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $11,277 and has fallen 99.0% since, to $118 in 2025. Among geriatric medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $828.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$11K
- Novo Nordisk$432
- Lilly USA, LLC$52
Across 55 payments — averaging $3426.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$188K
What the payments were for
- Consulting fees$5,15644%
- Travel & lodging$5,73349%
- Food & beverage$7126%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 5 | $11,118 |
| Novo Nordisk | 7 | $432 |
| Lilly USA, LLC | 2 | $52 |
How this compares
$11,602 in reported general payments places this provider in the 95th percentile of 77 geriatric medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 108 | $3,222 |
| Galantamine ErGalantamine Hbr | 17 | $1,180 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $429 |
| Donepezil Hcl | 43 | $427 |
| Trazodone Hcl | 29 | $207 |
| Buspirone Hcl | 15 | $138 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Seattle
- Sabine von Preyss-FriedmanSeattle$3K
- Ellyn LeeSeattle$2K
- Michi YukawaSeattle$2K
- James LinSeattle$126
- Richard ArnoldSeattle$64
- Assadullah KazemiSeattle$62
- John ChenSeattle$23
- Paul BeckSeattle$23
- Taisha DooSeattle$22
- Sarah BabineauSeattle$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.